Sorry, but common shareholders do not benefit in any way from this deal. They get nothing.
The belief that the assets sold for more than $100 million is ridiculous. Not only do the fact say otherwise, if the amount was over $40 million, then Mitsui would be paid in full and there would be no need to object, would there? That just confirms again the final sale amount is much too low to even pay off all the secured creditors, much less the common shareholders.
If anyone has actual BIOAQ share certificate, they can be hung on the wall as art. But otherwise, that will be the only thing the shareholders will get.
